NASDAQ:ATHA
Athira Pharma, Inc. Stock News
$2.62
+0.0900 (+3.56%)
At Close: May 31, 2024
ATHA SHAREHOLDER ALERT: Shareholders With Substantial Losses Have Opportunity to Lead the Athira Pharma, Inc. Class Action Lawsuit
05:12pm, Thursday, 15'th Jul 2021
San Diego, California--(Newsfile Corp. - July 15, 2021) - The Athira Pharma class action lawsuit charges Athira Pharma, Inc. (NASDAQ: ATHA) and its CEO with violations of the Securities Exchange Act o
San Francisco, California--(Newsfile Corp. - July 15, 2021) - Hagens Berman urges Athira Pharma, Inc. (NASDAQ: ATHA) investors with significant losses to submit your losses now. A securities class act
Los Angeles, California--(Newsfile Corp. - July 15, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athira Pharma, In
Radnor, Pennsylvania--(Newsfile Corp. - July 14, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds Athira Pharma, Inc. (NASDAQ: ATHA) ("Athira") investors that securities fraud class
ATHA INVESTOR ALERT: Investors With Substantial Losses Have Opportunity to Lead the Athira Pharma, Inc. Class Action Lawsuit
12:10pm, Wednesday, 14'th Jul 2021
SAN DIEGO--(BUSINESS WIRE)-- #ATHAstock--The suit alleges defendants issued false statements concerning Athira business and prospects, resulting in its stock trading at inflated prices.
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Athira Pharma, Inc. (ATHA) Investors
11:25am, Wednesday, 14'th Jul 2021
LOS ANGELES, July 14, 2021 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired
Los Angeles, California--(Newsfile Corp. - July 14, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athira Pharma, In
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Athira Pharma, Inc. - ATHA
08:05pm, Tuesday, 13'th Jul 2021
New York, New York--(Newsfile Corp. - July 13, 2021) - Pomerantz LLP is investigating claims on behalf of investors of. Athira Pharma, Inc. ("Athira" or the "Company") (NASDAQ: ATHA). Such investors
Athira Shareholder Alert
07:40pm, Tuesday, 13'th Jul 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Athira To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Cor
San Francisco, California--(Newsfile Corp. - July 13, 2021) - Hagens Berman urges Athira Pharma, Inc. (NASDAQ: ATHA) investors with significant losses to submit your losses now. A securities class act
Los Angeles, California--(Newsfile Corp. - July 13, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athira Pharma, In
RADNOR, Pa., July 12, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that securities fraud class action lawsuits have been filed against Athira Pharma, Inc.
Los Angeles, California--(Newsfile Corp. - July 12, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Athira Pharma, In
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Athira Pharma, Inc. (NASDAQ: ATHA): (a) pursuant and/or traceable to the Comp
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Athira Pharma, Inc. - ATHA
07:30am, Saturday, 10'th Jul 2021
NEW YORK, July 10, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of. Athira Pharma, Inc. ("Athira" or the "Company") (NASDAQ: ATHA).
